Utpal Koppikar
Board Member
C4 Therapeutics, Inc. (CCCC)Equibles does not estimate personal net worth.
Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CCCC alertsAbout Utpal Koppikar
Utpal Koppikar is recorded as Board Member at C4 Therapeutics, Inc. (CCCC) since March 16, 2022. C4 Therapeutics, Inc. reported in an 8-K filed March 16, 2022 that Utpal Koppikar was appointed director, effective March 16, 2022. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.
“On March 16, 2022, the Board of Directors (the “Board”) of C4 Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Utpal Koppikar as a director effective immediately and as chair of the Audit Committee of the Board effective March 17, 2022.”
Affiliation history
-
Current
2022-03-16–present
Company network
Leadership on record at C4 Therapeutics, Inc.
- Andrew J. Hirsch CEO
- Andrew Phillips CEO
- Ron Cooper Chairman, Board Member
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White CFO, Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Laura Bessen, M.D. Board Member